Phase II Study of S-1 Plus Leucovorin (New 1 Week Treatment Regimen Followed by 1 Week Rest Period) in Patients with Untreated Metastatic Colorectal Cancer in Japan and China
Hideo Baba, J. Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), J. Li(Fudan University), Yasushi Toh(National Hospital Organization Kyushu Cancer Center), Tadamichi Denda(Chiba Cancer Center), Lin Shen(Peking University), Ayumi Matsuyama(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Tadafumi Kato(Juntendo University), Rui‐Hua Xu(Sun Yat-sen University), Koji Ikejiri(National Kyushu Medical Center), K. Shimada(Showa University Northern Yokohama Hospital), Kenji Sakai(Doshisha University), H. Mishima(Osaka National Hospital), Jian Xu(University of California, Los Angeles)
Cited by 1
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868